Cargando…
Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
In the popular biomarker-focused session at JADPRO Live 2022, presenters paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and reviewed recommendations and guidelines for biomark...
Autores principales: | Faiman, Beth, Kurtin, Sandra E., Persinger, Rasheda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184845/ https://www.ncbi.nlm.nih.gov/pubmed/37197733 http://dx.doi.org/10.6004/jadpro.2023.14.3.8 |
Ejemplares similares
-
Biomarker Jeopardy
por: Kurtin, Sandra E., et al.
Publicado: (2021) -
Biomarker Jeopardy
por: Kurtin, Sandra E., et al.
Publicado: (2022) -
Biomarker BINGO
por: Held, Lauren, et al.
Publicado: (2020) -
The Landscape of the Advanced NSCLC Treatment Paradigm: Molecular Testing and Actionable Mutations
por: Persinger, Rasheda
Publicado: (2021) -
A Call to Action: The Role of the Oncology AP in Equitable Cancer Care
por: Hoffner, Brianna, et al.
Publicado: (2022)